Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $380.1 million.

  • Privia Health's Non-Current Assets rose 3024.17% to $380.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $380.1 million, marking a year-over-year increase of 3024.17%. This contributed to the annual value of $301.0 million for FY2024, which is 62.32% up from last year.
  • Privia Health's Non-Current Assets amounted to $380.1 million in Q3 2025, which was up 3024.17% from $389.6 million recorded in Q2 2025.
  • Privia Health's Non-Current Assets' 5-year high stood at $389.6 million during Q2 2025, with a 5-year trough of $143.6 million in Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $286.6 million (2023), whereas its average is $266.0 million.
  • Per our database at Business Quant, Privia Health's Non-Current Assets skyrocketed by 7258.67% in 2021 and then plummeted by 210.09% in 2025.
  • Over the past 5 years, Privia Health's Non-Current Assets (Quarter) stood at $239.7 million in 2021, then increased by 0.48% to $240.9 million in 2022, then increased by 24.18% to $299.1 million in 2023, then rose by 0.62% to $301.0 million in 2024, then grew by 26.28% to $380.1 million in 2025.
  • Its Non-Current Assets was $380.1 million in Q3 2025, compared to $389.6 million in Q2 2025 and $297.1 million in Q1 2025.